Targeting hexokinase II to mitochondria to modulate energy metabolism and reduce ischaemia-reperfusion injury in heart. - Wikidata - awgldk - TriplyDB

Targeting hexokinase II to mitochondria to modulate energy metabolism and reduce ischaemia-reperfusion injury in heart.

Targeting hexokinase II to mitochondria to modulate energy metabolism and reduce ischaemia-reperfusion injury in heart.

http://www.wikidata.org/entity/Q37686277

about

Role of the MPTP in conditioning the heart - translatability and mechanism Impact of hypoglycemic agents on myocardial ischemic preconditioning Ischemic conditioning: the challenge of protecting the diabetic heart.Degradation of HK2 by chaperone-mediated autophagy promotes metabolic catastrophe and cell death Real-Time Fluorescence Measurements of ROS and [Ca2+] in Ischemic / Reperfused Rat Hearts: Detectable Increases Occur only after Mitochondrial Pore Opening and Are Attenuated by Ischemic Preconditioning.A randomized trial of remote ischemic preconditioning and control treatment for cardioprotection in sevoflurane-anesthetized CABG patients.Ginsenoside Rg5 increases cardiomyocyte resistance to ischemic injury through regulation of mitochondrial hexokinase-II and dynamin-related protein 1 The role of hexokinase in cardioprotection - mechanism and potential for translation.Hexokinases and cardioprotection.Dicer mediating the expression of miR-143 and miR-155 regulates hexokinase II associated cellular response to hypoxia.The role of succinate and ROS in reperfusion injury - A critical appraisal.Mitochondria as a target of cardioprotection in models of preconditioning.Reducing mitochondrial bound hexokinase II mediates transition from non-injurious into injurious ischemia/reperfusion of the intact heart.Cyclophilin D ablation is associated with increased end-ischemic mitochondrial hexokinase activity.Mitochondrial pharmacology: energy, injury and beyond.Increased in vivo mitochondrial oxygenation with right ventricular failure induced by pulmonary arterial hypertension: mitochondrial inhibition as driver of cardiac failure?New and revisited approaches to preserving the reperfused myocardium.Methylene Blue Protects the Isolated Rat Lungs from Ischemia-Reperfusion Injury by Attenuating Mitochondrial Oxidative Damage.HIF-1 reduces ischaemia-reperfusion injury in the heart by targeting the mitochondrial permeability transition pore.Targeting Liver Cancer and Associated Pathologies in Mice with a Mitochondrial VDAC1-Based Peptide.

P2860

Q26830560-29373284-729E-4821-BF45-D074E828A838 Q27014018-204B1D0D-9942-4C4A-B19A-1DB23071A5FA Q34457775-43025F36-5D3A-4931-B9CA-33EB5593E226 Q36014637-5D1BAA01-9B53-4B07-ABDC-FFBAF614EB69 Q36209994-4B9FE45B-3719-4D9E-9D39-C6C391532E0E Q36327207-AEF93D17-1BB5-4281-8F43-D23DFFC56B9A Q37745258-587F3897-4DC3-4721-81EB-94B621AD0167 Q38247510-671C36DE-252B-48D6-8748-472149D0814A Q38255143-D9F30B28-AAD1-4BC4-94F0-E84E88BFF70A Q38961504-5268AD9F-3F47-47D7-8A60-DB548561DF74 Q39423100-44DCD372-FB5F-4374-B240-8DA25F851331 Q39449539-67AC9328-9F8D-494F-ACD7-73438651AE1A Q42230588-D35FCEDB-62A8-49E4-8277-055047F3C095 Q42371836-B148E434-0A09-4E20-A02A-23DE0362B3B3 Q42374835-5152C6BA-1A79-442D-A350-9FDC5EAD6AD0 Q43137223-9AE3515A-6796-4C09-AD22-7E66769D9E5E Q45064238-3A92DA97-0F3A-4A11-A8B4-EDC184D5064F Q46248197-56E4109E-58D1-4726-8C63-1D5B527263FD Q54334859-56FCCA81-D80E-415D-A579-B55FF67856B3 Q55255442-A661492D-DB60-4160-89AB-9AFBEFFBDA96

P2860

Targeting hexokinase II to mitochondria to modulate energy metabolism and reduce ischaemia-reperfusion injury in heart.

http://www.wikidata.org/entity/Q37686277

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Targeting hexokinase II to mit ...... a-reperfusion injury in heart.

@en

Targeting hexokinase II to mit ...... a-reperfusion injury in heart.

@nl

type

label

Targeting hexokinase II to mit ...... a-reperfusion injury in heart.

@en

Targeting hexokinase II to mit ...... a-reperfusion injury in heart.

@nl

prefLabel

Targeting hexokinase II to mit ...... a-reperfusion injury in heart.

@en

Targeting hexokinase II to mit ...... a-reperfusion injury in heart.

@nl

P1433

Q37686277-ACCDF378-EDD0-44BC-85CF-D320712FB513

P1476

Q37686277-4FBE0389-9767-4D7D-AFD3-9F947D12AD98

P2093

Q37686277-27FFB244-D16B-4865-99C6-FD72EBFFECAD

Q37686277-33397D06-C1F5-4608-93EC-462DD3B3BA15

Q37686277-8E2AB4FD-849B-4E6B-9AED-20E6B23EFA3D

Q37686277-B015305E-B3C4-42B9-B5DC-32F483A74B9E

P2860

Q37686277-0454A438-1476-4843-A85E-64697B95E784

Q37686277-0910F967-4D35-45FE-A922-4D6FEAD4EAC2

Q37686277-0B5301B4-3F3D-4E8E-AA64-F38FFCD02E15

Q37686277-0BC08C5E-1D73-43B6-9414-296DCA445CEE

Q37686277-0CC0E150-CB31-4E62-A999-9334549A27C9

Q37686277-0D0826BD-DB25-4F10-BAD6-A4779D8E18F7

Q37686277-0D4E1145-9778-486C-958D-F4BD0D049664

Q37686277-0E942F2C-5BC8-4185-B870-7556473F50C3

Q37686277-0EBFF150-6475-41CC-A4B0-2C4C2D0B4F47

Q37686277-11791FB8-5EB9-4DD2-A1A6-A396FC4F1402

P304

Q37686277-9E07C541-B84B-433E-841E-EA9F0302D772

P31

Q37686277-BEB355E3-ABE9-4CE5-8C25-C79308E06BA6

P356

Q37686277-D22B7680-BC16-4E1A-9B16-FB3A6482FEA9

P407

Q37686277-9D5C359F-8772-4806-A227-DC0E5273E7DC

P433

Q37686277-AA434110-DD5F-45EF-936E-C61643D2A5CC

P478

Q37686277-6D874070-97B0-4F33-91B6-6AB7CA1DAC14

P50

Q37686277-230F2DD8-20BB-430F-8EF8-CDA08690136C

P577

Q37686277-BD9FD22E-FE94-4CE8-A914-29A63BB4BD82

P5875

Q37686277-9E16C75C-84E6-45C5-9AD7-4B1C1570D222

P698

Q37686277-E9041365-3F3A-4148-A122-63CD03D77E84

P921

Q37686277-DA129406-0A01-4DCB-A1E3-09B7EC15DE31

Q37686277-F78B57BE-9056-4C94-851E-70C83E1A9897

P932

Q37686277-0828BF6B-CADA-4917-9098-5E25E73C9046

P356

P1433

British Journal of Pharmacology

P1476

Targeting hexokinase II to mit ...... a-reperfusion injury in heart.

@en

P2093

Coert J Zuurbier

http://www.w3.org/2001/XMLSchema#string

Markus W Hollmann

http://www.w3.org/2001/XMLSchema#string

Otto Eerbeek

http://www.w3.org/2001/XMLSchema#string

Rianne Nederlof

http://www.w3.org/2001/XMLSchema#string

P2860

Hexokinase II detachment from mitochondria triggers apoptosis through the permeability transition pore independent of voltage-dependent anion channels

High aerobic glycolysis of rat hepatoma cells in culture: role of mitochondrial hexokinase

Metformin activates AMP kinase through inhibition of AMP deaminase

Hexokinase-2 bound to mitochondria: cancer's stygian link to the "Warburg Effect" and a pivotal target for effective therapy

Historical perspective on the pathology of myocardial ischemia/reperfusion injury

HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression

Targeting HIF-1 for cancer therapy

Warburg, me and Hexokinase 2: Multiple discoveries of key molecular events underlying one of cancers' most common phenotypes, the "Warburg Effect", i.e., elevated glycolysis in the presence of oxygen

Complexes between porin, hexokinase, mitochondrial creatine kinase and adenylate translocator display properties of the permeability transition pore. Implication for regulation of permeability transition by the kinases

Metabolic modulation of glioblastoma with dichloroacetate

P304

2067-2079

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BPH.12363

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

171

http://www.w3.org/2001/XMLSchema#string

P50

Richard Southworth

P577

2014-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256607269

http://www.w3.org/2001/XMLSchema#string

P698

24032601

http://www.w3.org/2001/XMLSchema#string

P921

reperfusion injury

P932

3976622

http://www.w3.org/2001/XMLSchema#string